PTAB/USPTO Update - September 2022

PTAB/USPTO Update - September 2022

Client Alert

Authors

USPTO Leadership

  • The USPTO announced new staff additions and promotions to its leadership team.
    •  Shirin Bidel-Niyat was elevated to Chief of Staff, having served previously as a senior advisor to Director Vidal.
    • Russell Lopez joined the USPTO as its Chief Communications Officer (CCO), having served previously as communications director for the California State Lottery.
    • Dede Zecher was promoted to Chief Advisor to the Director, having worked previously for the USPTO for 15 years. 

Notices, Guidance, and Requests

Final Rules

  • There are no new final rules.

Interim Rules

  • There are no new interim rules.

Proposed Rules

PTAB Decisions

  • New Precedential PTAB Decisions
    • Code200, UAB v. Bright Data, Ltd., IPR2022-00861 & IPR2022-00862, Paper 18 (Aug. 23, 2022) [AIA § 314(a), vacating decision denying institution – analysis of General Plastic factors relating to a second-filed petition when the first-filed petition was not evaluated on the merits] (sua sponte Director review decision)
  • New Informative PTAB Decisions
    • There are no new informative PTAB decisions.

New Requests for POP Review

  • Daiichi Sankyo, Inc. et al v. Seagen Inc. f/k/a Seattle Genetics, Inc. (PGR2021-00030) [Requesting POP review of De-Institution Decision on the basis that “[b]y discounting its finding of ‘strong merits’ solely based on a parallel jury verdict, the panel impermissibly abdicated its fact‐finding duty, instead deferring to a district court jury on whether review is warranted, and violated the very guidance on which it purported to rely”]
  • Sun Pharmaceutical Industries Limited v. Aurinia Pharmaceuticals Inc. (IPR2022-00617) [Requesting POP review of Institution Decision, presenting the question of whether institution based on arguments developed by the Board for threshold questions of patentability not raised in the petition is ultra vires and contravenes the requirements of 35 U.S.C. § 314(a), SAS Inst., Inc. v. Iancu, 138 S. Ct. 1348 (2018), and In re Magnum Oil Tools Int’l, Ltd., 829 F.3d 1364 (Fed. Cir. 2016) that the petition itself must establish a reasonable likelihood that the petitioner would prevail]
  • Freedom to Operate, Inc. v. COMPASS Pathways Limited (PGR2022-00012 and -00018) [Requesting POP review of Institution Decision “in order to confirm that a post-grant proceeding should be instituted where a Petitioner provides expert testimony from highly qualified experts who provide detailed reasoning and scientific basis to support their opinions that, if not rebutted, would demonstrate that it is more likely than not that at least 1 of the claims challenged in the petition is unpatentable”]
  • Liquidia Technologies, Inc. v. United Therapeutics Corporation (IPR2021-00406) [Requesting POP review of Institution Decision, presenting the following question: if a person of ordinary skill in the art must rely on a “research aid” to find a reference, does the date of public accessibility of that reference depend on the date on which the research aid became publicly accessible?]
  • Guardant Health, Inc. v. University of Washington (IPR2022-00449 and -00450) [Requesting POP review of Institution Decisions on the basis that the Board decision did not consider all prior Office evaluations, but instead deferred to one examiner’s action while leaving contrary evaluations unaddressed]
     

Authors

More From This Series

Notice

Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.